Tests have been made in a combustion turbine burner using six petroleum-derived surrogate (PDS) fuels simulating six coal-derived liquid (DCL) fuels tested earlier. The purpose being to examine their suitability for use in place of scarce CDL fuels for combustor development. The PDS and DCL fuels were matched in terms of aromaticity and fuel bound nitrogen although differences in viscosity, distillation range and constituent species existed. In three cases, the low fuel bound nitrogen present in the PDS fuels was made equal to their coal liquid counterparts via the addition of quinoline. All six PDS fuels were evaluated on a 0. 14-m-dia combustor while one of the surrogate fuels was evaluated on a 0.3-m-dia Westinghouse commercial combustor.nitrogen content while combustor wall temperature and smoke are related to hydrogen deficiency (i.e., aromaticity) of the CDL fuels. For both the PDS and CDL fuels, aromaticity is defined as the percentage of aromatic carbon atoms in the fuel relative to the
Combustion tests on over twelve types of coal derived liquid fuels from the EDS, H-coal, SRC-I and SRC-II processes and three shale oil fuels have been conducted in gas turbine type combustors. Emission measurements were made of Nox, smoke, CO, and unburned hydrocarbons. Combustor wall temperature profiles were measured. The results are correlated with the fuel properties-percent nitrogen, hydrogen and aromaticity. This part of the paper discusses the fuels used in subscale combustion tests along with the test results. A companion paper (Part II) describes the results of full-scale combustor tests and a long term corrosion/deposition test.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.